Erratum: Comparison of Intra-Articular Injections of Plasma Rich in Growth Factors (PRGF-Endoret) Versus Durolane Hyaluronic Acid in the Treatment of Patients With Symptomatic Osteoarthritis: A Randomized Controlled Trial (Arthroscopy: The Journal of Arthroscopic and Related Surgery (2013) 29(10) (1635–1643), (S0749806313008190), (10.1016/j.arthro.2013.07.264));Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: A randomized controlled trial

Arthroscopy - Journal of Arthroscopic and Related Surgery

Volumn 29, Issue 10, 2013, Pages 1635-1643

  Vaquerizo, Víctor ^a   Plasencia, Miguel Ángel ^a   Arribas, Ignacio ^a   Seijas, Roberto ^b   Padilla, Sabino ^c   Orive, Gorka ^c   Anitua, Eduardo ^c  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b HOSPITAL QUIRÓN   (Spain)

^c Biotechnology Institute (BTI ImasD)   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENDORET; HYALURONIC ACID; RECOMBINANT GROWTH FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; KNEE OSTEOARTHRITIS; KNEE PAIN; LEQUESNE SCORE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; RANDOMIZED CONTROLLED TRIAL; RIGIDITY; SINGLE DRUG DOSE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

EID: 84884874144     PISSN: 07498063     EISSN: 15263231     Source Type: Journal    
DOI: 10.1016/j.arthro.2024.03.034     Document Type: Erratum

References (30)

1. M.R. Kosorok, G.S. Omenn, P. Diehr, T.D. Koepsell, and D.L. Patrick Restricted activity days among older adults Am J Public Health 82 1992 1263 1267
2. A.A. Guccione, D.T. Felson, and J.J. Anderson The effects of specific medical conditions on the functional limitation of elders in the Framingham Study Am J Public Health 84 1994 351 358
3. J.W.J. Bijlsma, F. Berenbaum, and F.P.J.G. Lafeber Osteoarthritis: An update with relevance for clinical practice Lancet 377 2011 2115 2126
4. Centers for Disease Control and Prevention (CDC) Prevalence of disabilities and associated health conditions among adults MMWR Morb Mortal Wkly Rep 50 2001 120 125
5. W. Zhang, R.W. Moskowitz, and G. Nuki OARSI recommendations for the management of hip and knee osteoarthritis, part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence Osteoarthritis Cartilage 15 2007 981 1000
6. X. Ayral, E.H. Pickering, T.G. Woodworth, N. Mackillop, and M. Dougados Synovitis: A potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - Results of a 1 year longitudinal arthroscopic study in 422 patients Osteoarthritis Cartilage 13 2005 361 367
7. D. Heinegard, and T. Saxne The role of the cartilage matrix in osteoarthritis Nat Rev Rheumatol 7 2011 50 56
8. E. Anitua, M. Sánchez, G. Orive, and I. Andía The potential impact of the preparation rich in growth factors (PRGF) in different medical fields Biomaterials 28 2007 4551 4560
9. E. Anitua, M. Sánchez, and G. Orive Potential of endogenous regenerative technology for in situ regenerative medicine Adv Drug Deliv Rev 62 2010 741 752
10. M. Sánchez, E. Anitua, J. Azofra, J.J. Aguirre, and I. Andia Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: A retrospective cohort study Clin Exp Rheumatol 26 2008 910 913
11. G. Filardo, E. Kon, and M.T. Pereira Ruiz Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: Single- versus double-spinning approach Knee Surg Sports Traumatol Arthrosc 20 2012 2082 2091
12. M. Sánchez, N. Fiz, and J. Azofra A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis Arthroscopy 28 2012 1070 1078
13. R.D. Altman, C. Akermark, A.D. Beaulieu, T. Schnitzer, and Durolane International Study Group Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee Osteoarthritis Cartilage 12 2004 642 649
14. Leighton RK, Arden N. A randomized blinded trial comparing one HA injection to corticosteroid for knee osteoarthritis pain. Presented at the American Academy of Orthopaedic Surgeons Annual Meeting; New Orleans, LA; March 2010. PN 640: 583.
15. D. Samper Bernal, Y. Jiménez Capel, and M. Hinojosa Zaguirre Efectividad y seguridad de la viscosuplementación con dosis única de ácido Hialurónico estabilizado de origen no animal (NASHA) para el tratamiento del dolor secundario a gonartrosis Rev Soc Esp Dolor 19 2012 259 263
16. R. Altman, E. Asch, and D. Bolch Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee Arthritis Rheum 29 1986 1039 1049
17. N. Bellamy, W.W. Buchanan, and C.H. Goldsmith Validation study of WOMAC: A health status instrument for measuring clinically, important patient, relevant outcomes following total hip or knee arthroplasty in an osteoarthritis J Orthop Rheumatol 1 1988 95 108
18. T. Pham, D. van der Heijde, and R.D. Altman OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited Osteoarthritis Cartilage 12 2004 389 399
19. M.G. Lequesne, C. Mery, and M. Samson Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment tests Scand J Rheumatol Suppl 65 1987 85 89
20. A. Wang-Saegusa, R. Cugat, O. Ares, R. Seijas, X. Cuscó, and M. García-Balletbó Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life Arch Orthop Trauma Surg 131 2011 311 317
21. M.C. Rowbotham What is a "clinically meaningful" reduction in pain? Pain 94 2001 131 132
22. F. Salaffi, A. Stancati, C.A. Silvestri, A. Ciapetti, and W. Grassi Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale Eur J Pain 8 2004 283 291
23. T. Yoshioka, A. Kanamori, and T. Washio The effects of plasma rich in growth factors (PRGF-Endoret) on healing of medial collateral ligament of the knee Knee Surg Sports Traumatol Arthrosc 21 2013 1763 1769
24. G. Filardo, E. Kon, and A. Di Martino Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: Study design and preliminary results of a randomized controlled trial BMC Musculoskelet Disord 13 2012 229
25. E. Kon, B. Mandelbaum, and R. Buda Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: From early degeneration to osteoarthritis Arthroscopy 27 2011 1490 1501
26. M.B. Schmidt, E.H. Chen, and S.E. Lynch A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair Osteoarthritis Cartilage 14 2006 403 412
27. J.A. Martin, and J.A. Buckwalter The role of chondrocyte-matrix interactions in maintaining and repairing articular cartilage Biorheology 37 2000 129 140
28. A. Frazer, R.A. Bunning, M. Thavarajah, J.M. Seid, and R.G. Russell Studies on type II collagen and aggrecan production in human articular chondrocytes in vitro and effects of transforming growth factor-beta and interleukin-1beta Osteoarthritis Cartilage 2 1994 235 245
29. G.M. van Buul, W.L. Koevoet, and N. Kops Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes Am J Sports Med 39 2011 2362 2370
30. J.P. Pujol, C. Chadjichristos, and F. Legendre Interleukin-1 and transforming growth factor-beta 1 as crucial factors in osteoarthritic cartilage metabolism Connect Tissue Res 49 2008 293 297